What's Happening
- Ro co-founder and CEO Zach Reitano discussed the development of the company's new AI agent.
- The executive outlined the business decisions driving the company's shift toward the next era of consumer health during Business Insider's The Long Play event.
- Reitano shared his experiences leading the healthcare platform through nine years of market changes in a conversation with Business Insider legal correspondent Melia Robinson.
Why It Matters
Healthcare platforms face pressure to integrate artificial intelligence while managing shifts in consumer demand. Ro's transition from basic direct-to-patient services to complex treatments like GLP-1s highlights the rapid evolution of digital health. The addition of an AI agent signals a push to automate and scale patient interactions.
Members read this in full
Membership is free. Sign in with your work email or with LinkedIn.
Join CIOs and AI leaders from Citibank, Pfizer and more
or continue with email
Have an invite? Open your invite link to join instantly.